Determination of CFTR densities in erythrocyte plasma membranes using recognition imaging

被引:27
作者
Ebner, Andreas [2 ]
Nikova, Dessy [1 ]
Lange, Tobias [1 ]
Haeberle, Johannes [3 ]
Falk, Sabine [3 ]
Duebbers, Angelika [3 ]
Bruns, Reimer [1 ]
Hinterdorfer, Peter [2 ]
Oberleithner, Hans [1 ]
Schillers, Hermann [1 ]
机构
[1] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany
[2] Univ Linz, Inst Biophys, A-4040 Linz, Austria
[3] Univ Hosp Munster, Dept Pediat, D-48149 Munster, Germany
关键词
D O I
10.1088/0957-4484/19/38/384017
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
CFTR ( cystic fibrosis transmembrane conductance regulator) is a cAMP-regulated chloride (Cl-) channel that plays an important role in salt and fluid movement across epithelia. Cystic fibrosis (CF), the most common genetic disease among Caucasians, is caused by mutations in the gene encoding CFTR. The most predominant mutation, F508del, disturbs CFTR protein trafficking, resulting in a reduced number of CFTR in the plasma membrane. Recent studies indicate that CFTR is not only found in epithelia but also in human erythrocytes. Although considerable attempts have been made to quantify CFTR in cells, conclusions on numbers of CFTR molecules localized in the plasma membrane have been drawn indirectly. AFM has the power to provide the needed information, since both sub-molecular spatial resolution and direct protein recognition via antibody-antigen interaction can be observed. We performed a quantification study of the CFTR copies in erythrocyte membranes at the single molecule level, and compared the difference between healthy donors and CF patients. We detected that the number of CFTR molecules is reduced by 70% in erythrocytes of cystic fibrosis patients.
引用
收藏
页数:6
相关论文
共 43 条
[41]   Atomic force microscopy of the erythrocyte membrane skeleton [J].
Swihart, AH ;
Mikrut, JM ;
Ketterson, JB ;
MacDonald, RC .
JOURNAL OF MICROSCOPY-OXFORD, 2001, 204 :212-225
[42]   Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients [J].
Verloo, P ;
Kocken, CHM ;
Van der Wel, A ;
Tilly, BC ;
Hogema, BM ;
Sinaasappel, M ;
Thomas, AW ;
De Jonge, HR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10316-10322
[43]  
Wilson PD, 1999, EXP NEPHROL, V7, P284